MGMaria Luiza Nogueira Dias Genta

Maria Luiza Nogueira Dias Genta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Luiza Nogueira Dias Genta has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Andre Lopes

    Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil; A.C. Camargo Cancer Center, São Paulo, Brazil

    4 shared publications
  • Rossana Verónica Mendoza López

    Cancer Institute of the State of São Paulo, Brazil

    4 shared publications
  • Cristina Anton

    Setor de Ginecologia Oncológica, Divisão de Ginecologia do Instituto do Câncer do Estado de São Paulo (ICESP) ‐ Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) São Paulo São Paulo Brazil

    3 shared publications
  • Jesus Paula Carvalho

    Universidade de Sao Paulo, Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Instituto do Cancer do Estado de São Paulo, Department of Obstetrics and Gynecology, Sao Paulo, Brazil

    3 shared publications
  • Jesus Paula Carvalho

    Department of Obstetrics and Gynecology Faculty of Medicine Universidade de São Paulo São PauloSP Brazil Department of Obstetrics and Gynecology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil

    3 shared publications
  • Maria Del Pilar Estevez Diz

    Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil; Instituto D'Or de Ensino e Pesquisa (IDOR), São Paulo, Brazil

    3 shared publications

Latest Publications

  • Open Access

    Hemangioma cavernoso uterino

    by Bárbara Nascimento Santana, Rafael Bispo Paschoalini, Denise Fabbron Aragão Leite, Maria Luiza Nogueira Dias Genta

    Hemangiomas na cavidade uterina são raros e relatados como diagnóstico diferencial de outras lesões uterinas de aspecto polipoide, incluindo malignidade. Trata-se de um caso de hemangioma com sangramento uterino, cujos achados histeroscópicos eram sugestivos de pólipo endometrial. É apresentada uma revisão da literatura dos hemangiomas uterinos, com ênfase em seu comportamento biológico e tratamento.

  • Open Access

    Role of dynamic ctDNA monitoring in cervical and anal epidermoid carcinomas under curative chemoradiation

    by Camila M.VEnchiarutti Moniz, Renata Colombo Bonadio, Felippe Lazar, Andre Tsin Chih Chen, Renan Ribeiro e Ribeiro, Mariana Siqueira, Maria Ignez Braghiroli, Marcela Crosara, Cinthia Ortega, Caio Nahas, et al.

  • Open Access

    Forkhead Box protein A1 is a prognostic biomarker for HPV-positive cervical squamous cell carcinoma

    by Milena Giulia Gonçalves, Rossana Verónica Mendoza López, Rafaella Almeida Lima Nunes, Thais Queiroz da Rocha, Luisa Lina Villa, Maria Luiza Nogueira Dias Genta, Laura Sichero

    Forkhead box protein A1 (FOXA1) is linked to cancer development in different anatomical sites. We previously demonstrated that FOXA1 markedly increases high-risk human papillomavirus (HPV) transcription by directly binding to the long control region (LCR). Herein, we aimed to assess FOXA1 levels and its prognostic significance in cervical cancer (CC). Methods: Patients with CC treated at the Instituto do Cancer do Estado de São Paulo (ICESP), Brazil, were included. FOXA1 levels were measured using immunohistochemistry (IHC). Results: Overall, FOXA1 staining was observed in 85% (208/245) of the samples, primarily localized in both the nucleus and cytoplasm (71%). High FOXA1 staining was more frequently detected in squamous cell carcinoma (SCC) compared to adenocarcinomas (ADC) (p = 0.003). High FOXA1 staining was significantly associated with HPV-positive CC (p = 0.005), with worse overall survival (OS) and disease-free survival (DFS) when considering all CC samples, as well as when restricting the analysis to SCC cases. Among HPV-positive cases, high FOXA1 staining was also significantly associated with poorer OS or DFS in women with SCC. Finally, high FOXA1 staining was associated with poor OS (HR 1.79; 95% CI: 1.14–2.79; p = 0.011) and poor DFS (HR: 1.64; 95% CI: 0.98–2.74; p = 0.056) among SCC cases in comparison to cases with low/moderate staining. No association was found between FOXA1 levels and prognosis in ADC. Conclusions: Our data suggest that FOXA1 may be involved in HPV-induced carcinogenesis and could serve as a prognostic biomarker in patients with cervical SCC.

  • Six cycles of neoadjuvant chemotherapy followed by cytoreduction in high-grade serous ovarian cancer: prognostic implications of the chemotherapy response score, CA-125, and tumor-infiltrating lymphocytes

    by Andre Lopes, Marilia Albanezi Bertolazzi, Samantha Cabral Severino da Costa, Valesca Bizinoto, Rossana Veronica Mendoza Lopez, Maria Luiza Nogueira Dias Genta, Jesus Paula Carvalho, Filomena Marino Carvalho


  • Open Access

    Analysis of Sentinel Lymph Node Adoption Compared to Systematic Lymphadenectomy in Staging Early Endometrial Cancer at a Tertiary Center: An Ambispective Study

    by Rodrigo Pinto Fernandes, Cristina Anton, Marilia Bertolazzi, Maria Luiza Genta, André Lopes, Rossana Veronica Mendonza Lopez, José Antônio Orellana Turri, Rafael Bispo Paschoalini, Ricardo dos Reis, Arnaud Wattiez, et al.

    Objective: The purpose of this study was to assess the impact of changing endometrial carcinoma staging from systematic lymph node dissection to the sentinel lymph node approach.Methods: This is an ambispective study including patients with endometrial carcinoma (EC) limited to the uterus (FIGO 2018 IA/IB). From December 2015 to October 2021, a group of patients underwent systematic staging with lymph node dissection (LND). From December 2021 to April 2024, another group of patients underwent surgical staging with the sentinel lymph node‐indocyanine green (SLN) algorithm and pathology ultrastaging analisys. The groups were matched (1 LND: 1 SLN) based on age, body mass index (BMI), tumor type, tumor size, and myometrial invasion. The primary endpoints were lymph node involvement, length of surgery, and complications. Complications were classified according to the Common Terminology Criteria for Adverse Events (CTCAE) v5.0.Results: Two hundred fifty‐seven patients were surgically treated during the study period (156 in the LND cohort, 101 in the SLN cohort). Propensity score matching revealed two equivalent groups containing 84 patients each. The rate of positive lymph nodes was similar between the LND group (3.6%) and the SLN group (8.3%) (OR: 2.46, 95% CI: 0.61–9.84; p = 0.205). The length of surgery was significantly lower in the SLN group (152.2 ± 51.9 min) compared to the LND group (304 ± 77.8 min) (p < 0.001). Intraoperative blood loss greater than 100 mL was significantly lower in the SLN group (9.5%) compared to the LND group (29.8%) (p < 0.001). CTCAE grades requiring intervention (grades 3, 4, and 5) were higher in the LND group (14.3%) compared to the SLN group (4.8%) (p = 0.049).Conclusion: The transition from LND to SLN approach was similar compared to systematic lymphadenectomy, allowing the reduction of surgical length, blood loss and severity of complications without compromising surgical complications and lymph node positivity.


  • Open Access

    Biofilme fúngico: uma barreira implacável à cura da candidíase vulvovaginal em pacientes pós-radioterapia do câncer cervical

    by Rafael Bispo Paschoalini, Mateus Bach, Heloisa Waligora de Carvalho Lages, Maria Luiza Nogueira Dias Genta

    Candidíases persistentes constituem um desafio na clínica ginecológica, sobretudo quando associadas a formas de Cândida não-albicans, de modo a apresentarem resistência a tratamentos rotineiros. A formação de biofilmes fúngicos recentemente descrita para esses micro-organismos dificulta sobremaneira a ação dos antimicrobianos, de modo a acentuar a manutenção de um microambiente de resistência. Em pacientes tratadas de câncer do colo uterino com radioterapia, o efeito de radiação reduz os mecanismos locais de defesa, acentuando a patogenicidade do quadro e sua persistência. Sugere-se que as formas prevalentes de blastoconídeos sugestivos de formas não-albicans sejam referidas no exame de Papanicolaou. Ainda que o método apresente baixa sensibilidade e especificidade para confirmação de micro-organismos, o quadro persistente pode ser identificado, como no presente caso, alertando para a terapêutica vigorosa, principalmente em ambiente hospitalar e centros oncológicos, prevenindo a formação de biofilmes.

  • Role of systematic pelvic and para‐aortic lymphadenectomy in delayed debulking surgery after six neoadjuvant chemotherapy cycles for high‐grade serous ovarian carcinoma

    by Andre Lopes, Maria L. N. D. Genta, Vanessa da Costa Miranda, Andrea Aranha, Rossana V. M. Lopez, Dariane S. A. M. Piato, Cristina Anton, Filomena M. Carvalho, Maria del Pilar Esteves Diz, Jesus P. Carvalho

    Introduction: We analyzed the role of systematic pelvic and para‐aortic lymphadenectomy in delayed debulking surgery after six neoadjuvant chemotherapy (NACT) cycles for advanced high‐grade serous ovarian carcinoma.Materials and Methods: We retrospectively reviewed patients with advanced ovarian carcinoma who underwent NACT with carboplatin‐paclitaxel between 2008 and 2016. Patients were included only if they had FIGO IIIC‐IVB high‐grade serous carcinoma with clinically negative lymph nodes after six NACT cycles (carboplatin‐paclitaxel) and underwent complete or near complete cytoreduction. Patients with partial lymphadenectomy or bulky nodes were excluded. Patients who underwent systematic pelvic and aortic lymphadenectomy and those who did not undergo lymph node dissection were compared. Progression‐free and overall survivals were analyzed using the Kaplan–Meier method.Results: Totally, 132 patients with FIGO IIIC‐IVB epithelial ovarian carcinoma were surgically treated after NACT. Sixty patients were included (39 and 21 in the lymphadenectomy and nonlymphadenectomy group, respectively); 40% had suspicious lymph nodes before NACT. Patient characteristics, blood transfusion numbers, and complication incidence were similar between the groups. In the lymphadenectomy group, 12 patients (30.8%) had histologically positive lymph nodes and the surgical time was longer (229 vs. 164 min). The median overall survival in the lymphadenectomy and nonlymphadenectomy groups, respectively, was 56.7 (95% CI 43.4–70.1) and 61.2 (21.4–101.0) months (p = 0.934); the corresponding disease‐free survival was 8.1 (6.2–10.1) and 8.3 (5.1–11.6) months (p = 0.878). Six patients exclusively presented with lymph node recurrence.Conclusions: Systematic lymphadenectomy after six NACT cycles may have no influence on survival.


  • Open Access

    Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes

    by Cristina Anton, Rodolpho Truffa Kleine, Eric Mayerhoff, Maria Del Pilar Esteves Diz, Daniela De Freitas, Heloisa De Andrade Carvalho, João Paulo Mancusi De Carvalho, Alexandre Silva E Silva, Maria Luiza Nogueira Dias Genta, André Lopes De Faria E Silva, et al.

    Few reports have described the clinical and prognostic characteristics of endometrial cancer, which is increasing worldwide, in large patient series in Brazil. Our objective was to analyze the clinicopathological characteristics, prognostic factors, and outcomes of patients with endometrial cancer treated and followed at a tertiary Brazilian institution over a 10-year period.This retrospective study included 703 patients diagnosed with endometrial cancer who were treated at a public academic tertiary hospital between 2008 and 2018. The following parameters were analyzed: age at diagnosis, race, body mass index, serum CA125 level before treatment; histological type and grade, and surgical stage. Outcomes were reported relative to histological type, surgical staging, serum CA125, lymph-vascular space involvement (LVSI), and lymph-node metastasis. The median patient age at diagnosis was 63 (range, 27–93) years (6.4% were p = 0.001; recurrence: HR = 2.49, p = 0.004 and HR = 3.22, p = 0.001, respectively). Disease-free (p = 0.087) and overall survival (p = 0.368) did not differ significantly between patients with stage II and III disease. These results indicate that prognostic role of cervical involvement should be explored further. This study reports the characteristics and outcomes of endometrial cancer in a large population from a single institution, with systematic surgical staging, a predominance of minimally invasive procedures, and well-documented outcomes. Prognostic factors in the present study population were generally similar to those in other countries, though our patients’ tumors were larger than in studies elsewhere due to later diagnosis. Our unexpected finding of similar prognoses of stage II and III patients raises questions about the prognostic value of cervical involvement and possible differences between carcinomas originating in the lower uterine segment versus those originating in the body and fundus. The present findings can be used to guide public policies aimed at improving the diagnosis and treatment of endometrial cancer in Brazil and other similar countries.


  • Open Access

    Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival

    by Maria Luiza Nogueira Dias Genta, Toni Ricardo Martins, Rossana V Mendoza Lopez, José Carlos Sadalla, João Paulo Mancusi de Carvalho, Edmund Chada Baracat, José Eduardo Levi, Jesus Paula Carvalho

    Invasive cervical cancer (ICC) is the third most common malignant neoplasm affecting Brazilian women. Little is known about the impact of specific HPV genotypes in the prognosis of ICC. We hypothesized that HPV genotype would impact ICC clinical presentation and survival. Women diagnosed with ICC at the Instituto do Câncer do Estado de São Paulo (ICESP) between May 2008 and June 2012 were included in the study and were followed until December 2015. HPV genotype was detected from formalin-fixed paraffin-embedded (FFPE) tumor tissue samples using Onclarity™ system (BD Viper™ LT automated system). 292 patients aged 50±14 years were analyzed. HPVDNA was detected in 84% of patients. The HPV genotypes studied were: HPV16 (64%), HPV18 (10%), HPV33-58 (7%), HPV45 (5%), HPV31 (4%) and other high-risk HPV genotypes (11%). HPV genotypes showed different distributions regarding histological type and clinical stage. Patients were followed for 35±21 months. The overall survival at 5 years after diagnosis of cervical cancer was 54%. Age, clinical staging, histological type and multiple HPV genotypes infection detected in the same tumor specimen were associated with poorer overall survival on multivariate Cox proportional hazard analysis (p<0.05). No specific HPV genotype affected survival. Multiple HPV genotype infection was associated with poorer ICC survival in our study, compared with single genotype infection. HPV genotyping from FFPE tumor tissue using an automated assay such as the Onclarity BD™ assay provides a simpler alternative for routine clinical use. This is the largest study employing an automated HPV genotyping assay using FFPE of ICC. Multiple HPV genotype infection adversely influenced survival.


  • Laparoscopic Extrafascial Hysterectomy (Completion Surgery) After Primary Chemoradiation in Patients With Locally Advanced Cervical Cancer

    by Giovanni Favero, Juliana Pierobon, Maria Luiza Genta, Marcia Pereira Araújo, Giovanni Miglino, Maria Del Carmen Pilar Diz, Heloísa de Andrade Carvalho, Julia Tizue Fukushima, Edmund Chada Baracat, Jesus Paula Carvalho